EDAP TMS is the world leader in therapeutic ultrasound
Global leader in therapeutic ultrasound and present in the market for more than 30 years, EDAP TMS (NASDAQ: EDAP) develops, manufactures, promotes and distributes minimally-invasive medical devices for urology using ultrasound technology. EDAP TMS is actively operating worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. By constantly investing in Research & Development and partnering with internationally renowned medical research institutions, EDAP TMS has developed a strong valuable patent portfolio based on its innovative technologies.With its complete range of Robotic HIFU devices, EDAP TMS is the most innovative company in minimally-invasive treatment for localized prostate cancer. By combining the latest technologies in imaging and treatment modalities, EDAP TMS just introduced the Focal One® as the answer to all requirements for ideal focal therapy of prostate cancer as a complement to the existing Ablatherm® HIFU. As a pioneer and key player in the field of extracorporeal lithotripsy (ESWL), EDAP TMS introduced the first modular lithotripter. The latest generation of shock wave source is utilized exclusively by EDAP TMS in its Sonolith® range of ESWL systems (Sonolith® i-sys and Sonolith® i-move).